RAIN — Rain Oncology Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
- $44.03m
- -$33.29m
Annual cashflow statement for Rain Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -10.9 | -21.1 | -51.4 | -75.7 |
| Depreciation | ||||
| Non-Cash Items | 0.519 | 8.19 | 8.67 | 3.52 |
| Unusual Items | ||||
| Purchased R&D | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -0.827 | 1.61 | 5.19 | 8.93 |
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Net Change in Other Assets & Liabilities | ||||
| Cash from Operating Activities | -11.2 | -11.2 | -37.5 | -63.2 |
| Capital Expenditures | -0.144 | -0.024 | -0.128 | -0.008 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0 | -5.17 | -118 | 47.2 |
| Sale/Maturity of Investment | ||||
| Change in Net Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -0.144 | -5.19 | -118 | 47.2 |
| Financing Cash Flow Items | 0 | -0.166 | -11.9 | -3.47 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 2.5 | 69.5 | 122 | 53.2 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -8.83 | 53.1 | -34.1 | 37.2 |